ES 
EN 
Join us in shining a light on APOL1-mediated kidney disease — a condition disproportionately affecting people of African, Caribbean, and Latin American ancestry. Together, we can raise awareness, support patients, and push for advancements in research and treatment.
Let’s unite to amplify patient voices and drive meaningful change.
Speakers:
-Keisha Gibson, MD, MPH: UNC Chapel Hill
-Corynne Corbett: La salud negra importa
-Barbara Harrison, MS, CGC: Harvard University
To learn more about Apolipoprotein L1 (APOL1), please visit our rare kidney disease page by haciendo clic aquí.
Thank You To Our Sponsors
Platinum:
Bronze:
